Tralokinumab is a fully human IgG4 monoclonal antibody with a high affinity for IL-13 alone. Tralokinumabs potential anti-inflammatory activity prevents IL-13 receptor interaction and subsequent downstream signaling and can be used to study atopic dermat
CAS Number:
[1044515-88-9]
Target:
IL Receptor
* VAT and and shipping costs not included. Errors and price changes excepted